Academia.edu no longer supports Internet Explorer.
To browse Academia.edu and the wider internet faster and more securely, please take a few seconds to upgrade your browser.
2010 •
American Journal of Obstetrics and Gynecology
Prevention of mother-to-child transmission services as a gateway to family-based human immunodeficiency virus care and treatment in resource-limited settings: rationale and international experiences2007 •
2009 •
Journal of Women's Health
Gender and the Use of Antiretroviral Treatment in Resource-Constrained Settings: Findings from a Multicenter Collaboration2008 •
JAIDS Journal of Acquired Immune Deficiency Syndromes
Considerations in Using US-Based Laboratory Toxicity Tables to Evaluate Laboratory Toxicities Among Healthy Malawian and Ugandan Infants2010 •
Infectious Disease Clinics of North America
The Infectious Diseases Institute at Makerere University, Kampala, Uganda2011 •
JAIDS Journal of Acquired Immune Deficiency Syndromes
Safety and Efficacy of HIV Hyperimmune Globulin for Prevention of Mother-to-Child HIV Transmission in HIV-1–Infected Pregnant Women and Their Infants in Kampala, Uganda (HIVIGLOB/NVP STUDY)2011 •
Problem Statement: Post conflict nations face various problems in terms of delivering health services. Anti Retroviral Treatment (ART) programs in such regions also face numerous hurdles in accomplishing their set goals. One of the important barriers to increase ART coverage is the financial price of ARV medications. It would be important for the national authorities or other agencies to work towards reducing or subsidizing the prices of ARV drugs to increase access to such programs. Post conflict nations like Uganda, Mozambique, and Haiti have seen activities undertaken by local governments and other organizations in this direction. It is necessary to learn of these activities and their effect on ART coverage. Also, it would be important to learn if factors, other than ARV medication prices, are also responsible for influencing ART coverage in these countries. This essay attempts to review ART programs in terms of the above mentioned intentions. Research Objective: “To analyze the influence of financial price of drugs on ART coverage in post conflict regions-utilizing the examples of Uganda, Mozambique and Haiti” Methods: The study is a desk study on available material – both peer reviewed and grey literature on the topic of “activities of national authorities and other organisations to increase ART coverage in Uganda, Mozambique, and Haiti”. Findings: When analyzing the influence of financial price on ART coverage, it has been found that indeed the national authorities in all of the 3 countries –Uganda, Mozambique, and Haiti have shown political commitment and taken up activities to reduce the price of ARV medication and increase coverage. They have also been supported by UN agencies like WHO and UNAIDS, bilateral agencies like PEPFAR, and various NGOs in their implementation of ART programs. However, ART is still out of reach for most of the HIV patients in these countries. This is mainly because the ARV medication price ,which inspite of great reductions, is still very high for both the governments of these resource poor nations to procure and for the HIV patients of these nations to buy. Also there are other barriers which influence ART programs like dependence on external funding to maintain the functioning of these programs, political instability in some countries, inadequate health infrastructure to deliver ART, security issues, and social factors. Discussion: ART programs in Uganda, Mozambique, and Haiti have made a beginning and as noted in the findings there are factors other than ART price which also have an influence on ART coverage. Problems such as these abound, considering the poverty of resources and shortage of health workers in these nations. We have noted the differing ART coverage among individual post conflict countries but we also have noted that successful examples of delivering ART in resource poor settings have been demonstrated earlier. To further tackle these issues, there is a requirement of strong and decisive government support and also increased funding from international donor. In this regard, it is necessary to r examine these issues ;and the role of financial price and other factors on ART coverage in individual post conflict countries through field studies to obtain more clear opinions and answers.
Objective: The objective of the study was to describe the attitudes of human immunodeficiency virus (HIV)-infected women and other role players towards the World Health Organization (WHO) 2010 infant feeding guidelines. Design: This was formative evaluation research, carried out from September-November 2011. Setting: The study was conducted at Mulago Hospital, Kampala, Uganda. Subjects: Focus group discussions (FGDs) were held among five groups: HIV-infected pregnant women (9), HIV-infected postpartum mothers (10), HIV-infected peers (10), male partners (10), family members of the pregnant women (10) and key informants (12). Outcome measures: Descriptive data were collected through FGDs and key informant interviews. Results: With the exception of male partners, the majority of FGD participants and key informants who were health workers held a positive attitude towards exclusive breastfeeding. The introduction of complementary foods at six months while HIV-infected lactating mother continued to breastfeed was supported by all of the health workers, but by only a minority of participants from each focus group discussion. The majority of FGD participants and the health workers were in favour of an HIV-infected lactating mother taking antiretroviral (ARV) drugs during the breastfeeding period, rather than the infant. Conclusion: Three conclusions can be drawn from this study. Firstly, general attitudes towards the WHO 2010 infant feeding guidelines on exclusive breastfeeding were positive. Secondly, there were still fears about an HIV-infected mother introducing complementary foods at six months while continuing to breastfeed. Thirdly, all of the FGD participants and the majority of the health workers recommended that the mother should take ARV drugs in the lactating period. Peer reviewed. (Submitted: 2013-08-16. Accepted: 2013-11-23.) © SAJCN S Afr J Clin Nutr 2014;27(2):63-68
SSRN Electronic Journal
The Global Reach of HIV/AIDS: Science, Politics, Economics, and Research2000 •
Africa Today
Addressing the Impact of HIV/AIDS on Women and Children in Sub-Saharan Africa: PEPFAR, the U.S. Strategy2010 •
Clinics in Perinatology
Perinatal HIV and Its Prevention: Progress Toward an HIV-free Generation2010 •
JAIDS Journal of Acquired Immune Deficiency Syndromes
Immunogenicity of ALVAC-HIV vCP1521 in Infants of HIV-1–Infected Women in Uganda (HPTN 027)2014 •
JAIDS Journal of Acquired Immune Deficiency Syndromes
KIDS-ART-LINC Collaboration. Low risk of death, but substantial program attrition, in pediatric HIV treatment cohorts in Sub-Saharan Africa2008 •
International Journal of Epidemiology
Cohort Profile: The Paediatric Antiretroviral Treatment Programmes in Lower-Income Countries (KIDS-ART-LINC) Collaboration2008 •
Social Studies of Science
Adverse Events and Placebo Effects: African scientists, HIV, and ethics in the 'global health sciences'2010 •
Journal of the International AIDS Society
Trends in the clinical characteristics of HIV-infected patients initiating antiretroviral therapy in Kenya, Uganda and Tanzania between 2002 and 2009International Journal of STD & AIDS
Trends in clinical characteristics of HIV-infected patients initiating antiretroviral therapy in Shanghai from 2006 to 20112013 •
Tropical Medicine & International Health
Implementing family-focused HIV care and treatment: the first 2 years’ experience of the mother-to-child transmission -plus program in Abidjan, Côte d’Ivoire2009 •
2013 •
Journal of The International Aids Society
Uptake of family planning methods and unplanned pregnancies among HIV-infected individuals: a cross-sectional survey among clients at HIV clinics in Uganda2011 •
2010 •
2015 •
2007 •
Antiviral Therapy
Pharmacokinetics and acceptability of once- versus twice-daily lamivudine and abacavir in HIV type-1-infected Ugandan children in the ARROW Trial2010 •
2014 •
BMC Public Health
Asking the right questions: developing evidence-based strategies for treating HIV in women and children2011 •
2010 •
Clinical Infectious Diseases
Editorial Commentary: HIV/AIDS Care in Africa Today2005 •
BMC Infectious Diseases
Incidence and risk factors of severe adverse events with nevirapine-based antiretroviral therapy in HIV-infected women. MTCT-Plus program, Abidjan, Côte d'Ivoire2010 •
Reproductive Health
Determinants of male involvement in the prevention of mother-to-child transmission of HIV programme in Eastern Uganda: a cross-sectional survey2010 •
2012 •
BMC Infectious Diseases
Decreases in self-reported alcohol consumption following HIV counseling and testing at Mulago Hospital, Kampala, Uganda2014 •
Health Care for Women International
“Our Hands Are Tied Up”: Current State of Safer Conception Services Suggests the Need for an Integrated Care Model2014 •
2010 •
JAIDS Journal of Acquired Immune Deficiency Syndromes
Total Lymphocyte Count: Not a Surrogate Marker for Risk of Death in HIV-Infected Ugandan Children2008 •